Table 1 –

Patient Demographics

VARIABLE	DESCRIPTION/UNIT	ALL PATIENTS (N=62)
		Number of patients (%)	Median	Interquartil e Range (IQR)
AGE	Years		70	65-75
RACE	African American	11 (18)	.	.
	Asian	2 (3)	.	.
	Caucasian	48 (77)	.	.
	Multiracial	1 (2)	.	.
MR-BX INTERVAL	Days	.	38.5	25-53
PSA	ng/ml	.	3.51	1.99-5.42
PROSTATE VOLUME	ml	.	27.55	21-34
BIOPSY SCHEME	Tbx only	10 (16)	.	.
	*Tbx + TR-Sbx	41 (66)	.	.
	Tbx + TP-Sbx	10 (16)	.	.
	TP-Sbx only	1 (2)	.	.
NO. OF CANCEROUS FOCI PER PT.
	0	16 (26)	.	.
	1	37 (60)	.	.
	2	8 (13)	.	.
	3	1 (2)	.	.

^*4 patients had targeted biopsy only for seminal vesicle lesion

Numbers in parentheses represent percentages

Bx: Biopsy, PSA: Prostate-specific antigen, Tbx: Targeted biopsy, TR-Sbx: Transrectal systematic biopsy, TP-Sbx: Transperineal systematic biopsy